Clinical Trial Design Optimization and Problem Solving
|BTC 6213||4 Quarter Hours|
|Description||Discusses quantitative data analysis in creating dynamic drug-disease models, strategic market models, trial simulation models, and integrated financial models, which enable key variable analysis in clinical trial developments in real time. This integrated approach allows all decisions in the design to optimize value against both scientific and business criteria simultaneously and continuously. Offers students an opportunity to learn to take a complete view of the development process at the outset -- across time, across the portfolio, and at all levels in the organization. This allows for greater insight into a drug's potential early in the process and leads to a more focused program for promising compounds, including an optimized clinical trial design. It also allows for earlier cessation of unpromising clinical trials, saving time and funds. Prereq. (a) BTC 6210 and (b) RGA 6100 or PJM 6000.|
Course SectionsThere are no current sections scheduled for this course. Course numbers changed beginning with the Fall 2009 term. Please make sure you are using the current course number.